News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.



Urinary peptidomic profile predicts age-related chronic diseases, excessive fibrosis

By Marilynn Larkin NEW YORK (Reuters Health) - Researchers have produced and validated a urinary peptidomic profile (UPP) biomarker that distinguishes healthy from unhealthy aging based on fibrosis

Novel antibody delivery technology boosts immunotherapy against glioblastoma in mice

By Marilynn Larkin NEW YORK (Reuters Health) - A delivery technology based on glucosylated polymers conjugated onto antibodies enhanced the accumulation and safety of checkpoint blockade therapy in a

Dapagliflozin curbs albuminuria in CKD with or without diabetes

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with chronic kidney disease (CKD), with or without type 2 diabetes, the SGLT2 inhibitor dapagliflozin reduced albuminuria, according to data

UPDATE 1-WHO issues plan to prevent sexual abuse after Congo scandal

(Adds background) By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization issued its plan (https://bit.ly/3pq3MWI) on Thursday to prevent any further misconduct by aid workers deployed

REFILE-UV light from nail salon dryers may provoke lupus lesions

(Corrects formatting issue affecting some clients, no change to text) By Lisa Rapaport (Reuters Health) - Nail salon drying lamps that emit ultraviolet light may contribute to periungual cutaneous

UV light from nail salon dryers may provoke lupus lesions

By Lisa Rapaport (Reuters Health) - Nail salon drying lamps that emit ultraviolet light may contribute to periungual cutaneous lupus erythematosus lesions, according to case reports detailed in a

REFILE-WHO issues plan to prevent sexual abuse after Congo scandal

(Corrects formatting issue in first paragraph affecting some subscribers, no change to article) By Reuters Staff GENEVA (Reuters) - The World Health Organization issued its plan (

WHO issues plan to prevent sexual abuse after Congo scandal

GENEVA, Oct 21 (Reuters) - The World Health Organization issued its plan (https://bit.ly/3pq3MWI) on Thursday to prevent any further misconduct by aid workers deployed in its field operations after

Long-term spaceflight may be risky to brain health

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Cosmonauts who've returned from long-term space flight show changes in their blood biomarkers that indicate brain injury, a small pilot study

UPDATE 1-Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study

(Adds comments) By Reuters Staff BERLIN (Reuters) - A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against disease caused by

U.S. appeals court rules against nursing homes over COVID-19 lawsuits

By Tom Hals (Reuters) - In a setback to nursing-home operators facing hundreds of COVID-19 negligence and wrongful-death lawsuits, a federal appeals court on Wednesday said cases against two New

UPDATE 1-U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots

(Adds comment from infectious disease expert) By Reuters Staff (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday are considering several

Texas targets Roe v. Wade, urges U.S. Supreme Court to maintain abortion ban

By Andrew Chung (Reuters) - Texas on Thursday asked the U.S. Supreme Court to keep in place a law that imposes a near-total ban on abortion and urged the justices that if they quickly take up a legal

U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots

By Reuters Staff (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday are considering several recommendations for rollout of COVID-19 vaccine

EU regulator verdict on Moderna COVID-19 booster shot next week

By Reuters Staff LONDON (Reuters) - The European Union's drug regulator expects to announce the results of its review of Moderna's COVID-19 booster vaccine next week and also to start a rolling review

Sweden extends pause of Moderna vaccine for younger age group

By Reuters Staff STOCKHOLM (Reuters) - Sweden has extended the pause of Moderna's COVID-19 vaccine for people aged 30 and younger due to rare heart-related side effects, the public health agency said

Regret and defiance in Europe's vaccine-shy east as COVID-19 rages

By Janis Laizans and Tsvetelia Tsolova RIGA/SOFIA (Reuters) - As Latvia goes into lockdown and hospitals in Bulgaria and Romania buckle under a COVID-19 surge while Poland sells surplus vaccine doses,

EXCLUSIVE-EU decision on Russia's Sputnik V shot 'impossible' this year - source

By Emilio Parodi and Polina Nikolskaya (Reuters) - The EU drug regulator is unlikely to decide whether to approve Russia's Sputnik V coronavirus vaccine until at least the first quarter of 2022

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

By Reuters staff (Reuters) - The UK drug regulator added Guillain-Barré syndrome (GBS) as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on

No decline in health-related quality of life after radical cystectomy

By Reuters Staff NEW YORK (Reuters Health) - Radical cystectomy (RC) with urinary diversion does not appear to lead to a decline in health-related quality of life (HRQOL), according to a new study. RC

BP targets may not be 'one-size-fits-all'

By Megan Brooks NEW YORK (Reuters Health) - Ideal blood pressure targets may depend in part on the cardiovascular event for which an individual patient is most at risk, according to a new analysis of

British docs far more likely to be offered jobs if they are white

By Linda Carroll NEW YORK (Reuters Health) - White doctors in London are six times more likely to be offered jobs than their Black counterparts, a new report suggests. Data described in an article

After mergers, rural hospitals more likely to stop surgical services

By Brandon May NEW YORK (Reuters Health) - Rural hospitals that are acquired by larger hospitals or health systems are more likely to close their surgical services, and possibly their maternal- and

Paradoxical bronchospasm may go unrecognized in patients with COPD or asthma

By Megan Brooks NEW YORK (Reuters Health) - Paradoxical bronchospasm can represent a distinct and unrecognized phenotype of patients with obstructive lung diseases, a new study suggests. "Paradoxical

Russia reports cases of more contagious COVID-19 Delta subvariant

By Reuters Staff MOSCOW (Reuters) - Russia has reported "isolated cases" of COVID-19 with a sublineage of the Delta variant that is believed to be even more contagious, the state consumer watchdog's

Pfizer vaccine very effective against Delta variant in adolescents in Israel - study

By Reuters Staff JERUSALEM (Reuters) - The Pfizer/BioNTech COVID-19 vaccine is highly effective at preventing infection and symptomatic disease from the Delta variant among 12- to 18-year-olds,

Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study

By Reuters Staff BERLIN (Reuters) - Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine

CORRECTED-Breast-cancer-prediction tool for U.S. Black women eases risk stratification

(Clarifies author's name in para 3 of story originally posted on October 19. (Corrects Dr. Palmer's name and title.)) By Marilynn Larkin NEW YORK (Reuters Health) - A risk prediction tool for breast

MRI features distinguish different types of pediatric myelitis

By Marilynn Larkin NEW YORK (Reuters Health) - Magnetic resonance imaging (MRI) can help identify a rare antibody-mediated inflammatory demyelinating disorder of the central nervous system,

REFILE-Long-term survival in NSCLC similar with stereotactic ablative radiotherapy or surgery

(Refiling to fix formatting errors experienced by some clients.) By Lisa Rapaport NEW YORK (Reuters Health) - Long-term survival after stereotactic ablative radiotherapy is noninferior to surgery for

Plants may be useful in vaccine antigen production

By Reuters Staff (Reuters) - Plants could someday be used to produce COVID-19 vaccine antigens, according to researchers who are developing a nasal spray vaccine. Vaccines work by delivering antigens,

Long-term survival in NSCLC similar with stereotactic ablative radiotherapy or surgery

By Lisa Rapaport (Reuters Health) - Long-term survival after stereotactic ablative radiotherapy is noninferior to surgery for operable stage 1 non-small-cell lung cancer, a U.S. study suggests.

Drug improves liver health in patients with NASH

By Gene Emery (Reuters Health) - A phase 2b test of 247 people with active nonalcoholic steatohepatitis (NASH) has concluded that high-dose therapy with Inventiva Pharma's lanifibranor can lower

Experimental oral COVID-19 vaccine shows promise in monkeys

By Reuters Staff (Reuters) - A COVID-19 booster vaccine that can be given by mouth to people who already have antibodies from vaccination or prior infection has yielded promising results in monkeys

Children with mild COVID-19 may lack antibodies afterward

By Reuters Staff (Reuters) - Children who contract a mild case of COVID-19 may not develop antibodies to the virus afterward, a study from Australia suggests. Researchers compared 57 children and 51

Acquired mutations linked to fat metabolism, insulin sensitivity in chronic liver disease

By Marilynn Larkin NEW YORK (Reuters Health) - For the first time, acquired (somatic) mutations that impact metabolism and insulin sensitivity were identified in liver cells of patients with chronic

Restricting travel over vaccine type could be discrimination, PAHO warns

By Daina Beth Solomon MEXICO CITY (Reuters) - Countries should grant entry to vaccinated travelers regardless of which shot they received to prevent discrimination and facilitate business, a top

UPDATE 1-U.S. surgeons successfully test pig kidney transplant in human patient

(Adds comment from PETA in new final paragraph) By Nancy Lapid NEW YORK (Reuters) - For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the

Novavax tumbles after report on COVID-19 vaccine production delay

By Reuters Staff (Reuters) - Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its experimental COVID-19 vaccine that

Some young people who undergo HCT retain ability to conceive

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Young people who undergo hematopoietic-stem-cell transplantation (HCT) may be able to conceive even after being treated with highly gonadotoxic

Insulin resistance tied to higher risk of major depressive disorder

By Rob Goodier NEW YORK (Reuters Health) - Three proxies for insulin resistance each may predict incident major depressive disorder, according to new research. Combined with findings from other

INSIGHT-AI can see through you: CEOs' language under machine microscope

By Tommy Wilkes LONDON (Reuters) - Executives, beware! You could become your own worst enemy. CEOs and other managers are increasingly under the microscope as some investors use artificial

UPDATE 1-U.S. readies plan to vaccinate kids ages 5-11 against COVID-19

(Adds quotes from briefing, U.S. COVID-19 statistics) By Susan Heavey WASHINGTON (Reuters) - The Biden administration on Wednesday outlined its plan to vaccinate millions of U.S. children ages 5 to 11

'Broken heart' syndrome rising in women even before pandemic

By Reuters Staff NEW YORK (Reuters Health) - Takotsubo cardiomyopathy - a rare heart-brain disorder also known as broken heart syndrome - is becoming more common among middle-aged and older women and

U.S. surgeons successfully test pig kidney transplant in human patient

By Nancy Lapid NEW YORK (Reuters) - For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the recipient's immune system, a potentially major

Artificial intelligence can rapidly diagnose rare genetic diseases

By Megan Brooks NEW YORK (Reuters Health) - An artificial intelligence (AI)-based algorithm can quickly diagnose rare genetic diseases in critically ill children with high accuracy, allowing earlier

Can CBD oil help shrink lung tumors?

By Megan Brooks NEW YORK (Reuters Health) - An elderly woman with non-small-cell lung cancer who declined conventional treatments including surgery, chemotherapy and radiation experienced significant

Canada to require COVID-19 vaccinations for federal lawmakers

By Reuters Staff OTTAWA (Reuters) - Canada's House of Commons will require all lawmakers to be fully vaccinated against COVID-19 when they return to work next month, potentially locking out some

White House lays out plan to vaccinate kids ages 5 to 11

By Susan Heavey WASHINGTON (Reuters) - The Biden administration on Wednesday outlined its plan to vaccinate millions of kids ages 5 to 11 as soon as the COVID-19 shot is approved for younger children,

U.S. Supreme Court justice rejects challenge to Maine COVID-19 vaccine mandate

By Lawrence Hurley WASHINGTON (Reuters) - U.S. Supreme Court Justice Stephen Breyer on Tuesday turned away a religious challenge to a requirement that healthcare workers in Maine be vaccinated against

Brazil senators drop call for COVID-19 homicide charge against Bolsonaro

By Lisandra Paraguassu BRASILIA (Reuters) - Brazilian senators investigating the handling of the country's COVID-19 outbreak have dropped a recommendation from their draft report that President Jair

Gates Foundation to spend $120 mln to speed access to generics of Merck COVID-19 pill

By Julie Steenhuysen and Michael Erman (Reuters) - The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's

Only very old and sick die of COVID if vaccinated, Italian study shows

By Reuters Staff MILAN (Reuters) - People vaccinated against COVID-19 are highly unlikely to die of the disease unless very old and already badly ill before getting it, a study in Italy showed on

China's COVID-19 outbreak grows as cities race to trace infections

By Reuters Staff BEIJING (Reuters) - China reported a fourth day of new locally transmitted COVID-19 cases in a handful of cities across China, prompting alarmed local governments to double down on

Putin approves week-long Russian workplace shutdown as COVID-19 surges

By Alexander Marrow and Darya Korsunskaya MOSCOW (Reuters) - Russian President Vladimir Putin on Wednesday approved a government proposal for a week-long workplace shutdown at the start of November to

UK hospitals on the edge as government resists fresh COVID measures

By Alistair Smout LONDON (Reuters) - British hospitals are on the edge and people should wear masks and come forward for vaccines to stop them being overwhelmed by a rising wave of COVID-19 cases,

Pandemic impacts postpartum mother-infant bonding in multiple ways

By Marilynn Larkin NEW YORK (Reuters Health) - Pandemic-related grief, particularly depression, increased risks to maternal-infant bonding among postpartum women, whereas anxiety and health worries

Limited evidence supports many hematopoietic stem cell transplant guidelines

By Lisa Rapaport (Reuters Health) - Guidelines for hematopoietic stem cell transplants often are not supported by randomized clinical trials published in peer-reviewed journals, a new study finds.

Breast-cancer-prediction tool for U.S. Black women eases risk stratification

By Marilynn Larkin NEW YORK (Reuters Health) - A risk prediction tool for breast cancer in US Black women showed similar accuracy to current questionnaire-based models in a validation study, and seems

Omecamtiv mecarbil likely improves outcomes in severe heart failure

By Marilynn Larkin NEW YORK (Reuters Health) - In recently hospitalized patients with severe heart failure (HF), omecamtiv mecarbil (OM) reduced the composite endpoint of time to first HF event or

UPDATE 1-FDA proposes rule to make many hearing aids cheaper

(Adds Psaki comment, quotes from officials) By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed creation of a new category of over-the-counter (OTC) hearing aids to

FEATURE-NGOs scramble to dampen COVID-19's impact on people living with HIV

By Benjamin Ryan and Kim Harrisberg NEW YORK/PIETERMARITZBURG, South Africa (Thomson Reuters Foundation) - South African domestic worker Mabuyi Dlamini always dreaded the bumpy, day-long minibus

U.S. workers face layoffs as U.S COVID-19 vaccine mandates kick in

By Nathan Layne (Reuters) - Thousands of unvaccinated workers across the United States are facing potential job losses as a growing number of states, cities and private companies start to enforce

Pfizer/BioNTech COVID-19 vaccine highly protective in 12-18 age group - U.S. CDC study

By Reuters Staff (Reuters) - The Pfizer Inc/BioNTech SE COVID-19 vaccine was 93% effective in preventing hospitalizations among those aged 12 to 18, according to an analysis released by the U.S.

For many, COVID-19 hospitalizations resulted in hundreds of dollars in out-of-pocket spending

By Linda Carroll NEW YORK (Reuters Health) - During 2020, many hospitalized COVID-19 patients were hit with hundreds of dollars of out-of-pocket costs even when there were cost-sharing waivers, a new

Quit-smoking pill varenicline needs no assistance from nicotine patch

By Megan Brooks NEW YORK (Reuters Health) - Combining varenicline with the nicotine patch or extending the duration of smoking-cessation treatment does not increase quit rates compared with the

Is tramadol really safer than codeine for noncancer pain?

By Megan Brooks NEW YORK (Reuters Health) - Codeine may be a safer bet than tramadol for chronic noncancer pain, according to a retrospective, population-based study from Spain. Tramadol is

ECMO outcomes worse for second-wave COVID patients with ARDS

By Megan Brooks NEW YORK (Reuters Health) - Second-wave COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO) fared worse than first-wave COVID-19 patients treated with ECMO, a

Physical, mental toll of wild fires may have been underestimated

By Linda Carroll NEW YORK (Reuters Health) - Nearly all people surveyed during bushfires in Australia reported one or more physical symptoms that they attributed to smoke from the fires, a new study

Moscow imposes new COVID curbs as daily deaths break record

By Anton Zverev and Dmitry Antonov MOSCOW (Reuters) - Moscow's mayor announced four months of stay-home restrictions for unvaccinated over-60s on Tuesday and the Russian government proposed a

FACTBOX -Fake olive oil scandal that caused Spain's worst food poisoning epidemic in 1981

By Reuters Staff MADRID (Reuters) - A group of survivors of a mass rapeseed oil poisoning 40 years ago have occupied Madrid's El Prado Museum and have threatened to commit suicide if the Spanish

Poison survivors leave Spain's Prado, ending protest

By Sergio Perez and Michael Gore MADRID (Reuters) - Survivors of a mass food poisoning four decades ago occupied Madrid's El Prado art gallery for a few hours on Tuesday, threatening to commit suicide

EXCLUSIVE-WHO-led programme aims to buy antiviral COVID-19 pills for $10 -document

By Francesco Guarascio BRUSSELS (Reuters) - A World Health Organization-led programme to ensure poorer countries get fair access to COVID-19 vaccines, tests and treatments aims to secure antiviral

Older people in Moscow told to stay home for four months amid COVID surge

By Reuters Staff MOSCOW (Reuters) - The Moscow city government on Tuesday ordered elderly people to stay home for four months and told businesses to have at least 30% of staff work from home amid a

FDA proposes over-the-counter hearing aids for Americans

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed creation of a new category of over-the-counter (OTC) hearing aids to be sold directly to the millions of

ANALYSIS-Lack of vaccination passport, testing threaten Japan's reopening

By Elaine Lies and Rocky Swift TOKYO (Reuters) - Japan's lack of a vaccination passport and limited testing capacity is threatening ambitions to reopen the economy at a crucial year-end period when

U.S. FDA to allow mixing and matching of COVID-19 boosters- NYT

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration is planning to allow Americans to get a different booster shot of a COVID-19 vaccine than the one initially taken, the New York Times

Children fuel English COVID case rise after slow vaccine start

By Alistair Smout LONDON (Reuters) - The spread of COVID-19 among children in England is fuelling a rise in cases nationally and causing concern among some scientists that vaccines are being rolled

Earlier breast cancer screening would narrow mortality gap for Black women, U.S. study finds

By Reuters Staff (Reuters) - Racial disparities in breast cancer survival in the United States could be cut by more than half if Black women got mammograms every other year starting at age 40,

Course of pediatric lower respiratory tract infections not changed by antibiotics

By Lisa Rapaport (Reuters Health) - Children with lower respiratory tract infections have similar severity and duration of symptoms whether or not they receive antibiotics, results of a randomized

Medicare spent hundreds of millions on cancer drugs confirmed to have no benefit

By Linda Carroll (Reuters Health) - In 2017-2019, the health benefits program for U.S. seniors spent an estimated $569 million on four cancer drugs that had received accelerated approval but later

Blood GFAP a sensitive biomarker for early Alzheimer's disease

By Reuters Staff NEW YORK (Reuters Health) - Blood levels of glial fibrillary acidic protein (GFAP) are a sensitive biomarker for amyloid-beta pathology in the early stages of Alzheimer's disease (AD)

Teleneurology on par with in-person care for MS

By Megan Brooks NEW YORK (Reuters Health) - Adults with multiple sclerosis (MS) receiving teleneurology care have similar outcomes as peers receiving in-person care, new research indicates. "

Support for TNF-inhibitor monotherapy in COVID patients with RA and related diseases

By Reuters Staff NEW YORK (Reuters Health) - Pooled data from three international COVID-19 registries support the use of tumor-necrosis-factor inhibitor (TNFi) monotherapy in patients with rheumatoid

Biden administration asks U.S. Supreme Court to block Texas abortion law

By Andrew Chung and Lawrence Hurley WASHINGTON (Reuters) - President Joe Biden's administration on Monday asked the U.S. Supreme Court to block a Texas law that imposes a near-total ban on abortion

UPDATE 2-Colin Powell, U.S. soldier and diplomat, dies of COVID-19 complications

(Adds confirmation of multiple myeloma, details, White House quotes) By Reuters Staff WASHINGTON (Reuters) - Colin Powell, the first Black U.S. secretary of state, top military officer and national

UPDATE 1-Former U.S. Secretary of State Colin Powell dies of COVID complications -statement

(Adds quotes, details, reports of multiple myeloma diagnosis, paragraphs 2, 4, 7-11) By Reuters Staff WASHINGTON (Reuters) - Colin Powell, the first Black U.S. secretary of state and top military

EU evaluating use of Pfizer's COVID-19 vaccine in young children

By Reuters Staff (Reuters) - The European Union's medicines regulator said on Monday it has started evaluating the use of Pfizer Inc and BioNTech's COVID-19 vaccine in children between five and 11

Italian police use water cannon to break up health pass protest at port

By Reuters Staff TRIESTE, Italy (Reuters) - Italian police used water cannon and tear gas on Monday to clear a sit-in at the port of Trieste, where opponents of the government's mandatory COVID-19

WHO says it 'cannot cut corners' in approving India's Covaxin shot

By Reuters Staff BENGALURU (Reuters) - The World Health Organization on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its

Thailand to cease Sinovac vaccine use when stocks end this month

By Reuters Staff BANGKOK (Reuters) - Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said on Monday, having used the shot

Spain's 'Crying Room' seeks to banish mental health taboo

By Michael Gore MADRID (Reuters) - "Enter and cry," one sign tells visitors. "I too have anxiety," glows another notice in pink. There are phones in one corner with the names of people you can call

Oyster Point's drug becomes first FDA-approved nasal spray to treat dry eyes

By Reuters Staff (Reuters) - Oyster Point Pharma Inc's treatment for dry eye disease became the first U.S. approved nasal spray for the chronic condition on Monday, sending the drug developer's shares

Visual outcomes of cataract surgery usually favorable in patients with diabetes

By Reuters Staff NEW YORK (Reuters Health) - Two-thirds of patients with diabetes achieve a good visual outcome of 20/40 or better after cataract surgery, according to one of the largest studies to

REFILE-Valneva jumps on positive results for COVID-19 vaccine candidate

(Removes extraneous words in paragraph 4) By Reuters Staff PARIS (Reuters) - Valneva reported positive Phase III results on Monday for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001,

Valneva jumps on positive results for COVID-19 vaccine candidate

By Reuters Staff PARIS (Reuters) - Valneva reported positive Phase III results on Monday for its inactivated, adjuvanted COVID-19 vaccine candidate VLA2001, lifting its shares in a boost for the

South Africa regulator not authorising Russian COVID-19 vaccine for now

By Reuters Staff JOHANNESBURG (Reuters) - South Africa's drugs regulator said on Monday that it was not approving an emergency use application for Russia's Sputnik V COVID-19 shot for now, citing

Polio vaccination campaign to begin in Afghanistan

By Reuters Staff KABUL (Reuters) - Health workers in Afghanistan will begin a house-to-house polio vaccination drive next month after the new Taliban government agreed to support the campaign, the

Japan PM: new disease command centre may come after pandemic

By Reuters Staff TOKYO (Reuters) - Japanese Prime Minister Fumio Kishida said on Monday his plan to create a government agency to better fight infectious diseases has not changed but will come into

Three new Ebola cases confirmed in eastern Congo

By Reuters Staff BENI, Democratic Republic of Congo (Reuters) - Three new Ebola cases have been confirmed in eastern Democratic Republic of Congo, bringing the total to five in the last 10 days, the

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.


© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information